Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001209191-17-023171

Options or other derivatives

  • Director acquired 6,844 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Booth Bruce · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-03-24 Grant or award : show line 1 in the form Stock Option (right to buy) +6,844 6,844 D
Loading xslF345X03/doc4.xml…